Study shows first extensive and stable microbiome remodeling via B. infantis in infants

Evolve BioSystems, Inc. today announced positive results from their landmark clinical trial in support of Evivo™, an activated form of the beneficial bacteria Bifidobacterium longum subsp. infantis (B. infantis EVC001, ActiBif®). The study showed that providing dietary B. infantis EVC001 resulted in rapid, substantial, and persistent remodeling of the gut microbiome in breastfed infants. …read more

Source: EurekAlert

(Visited 17 times, 1 visits today)

Site Footer

Sliding Sidebar